Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-07-11
Cellectar Biosciences, Inc. (CLRB) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-11. 4 Form 8-K material event filings were reported by CLRB in the last 90 days. InsiderAlpha tracks every CLRB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001279704 |
|---|
| Form 4 filings (90d) | 12 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-07-11 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| CARUSO JAMES V | Chief Executive Officer | P — Open-market purchase | 8.7K | $2.88 | $25K | SEC | |
| Longcor Jarrod | Chief Operating Officer | P — Open-market purchase | 8.7K | $2.88 | $25K | SEC | |
| NEIS JOHN | Director | S — Open-market sale | 198 | $3.70 | $732 | SEC | |
| CARUSO JAMES V | Chief Executive Officer | P — Open-market purchase | 10.0K | $4.99 | $50K | SEC | |
| Longcor Jarrod | Chief Operating Officer | P — Open-market purchase | 10.0K | $4.99 | $50K | SEC | |
| Kolean Chad J | Chief Financial Officer | P — Open-market purchase | 5.0K | $4.99 | $25K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cellectar Biosciences, Inc. (CLRB). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| CARUSO JAMES V | 3 | $25K |
| Longcor Jarrod | 3 | $25K |
| Loren Stefan | 2 | — |
| NEIS JOHN | 1 | — |
| Chanan-Khan Asher | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CLRB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CLRB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.